Matches in Wikidata for { <http://www.wikidata.org/entity/Q63403278> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q63403278 description "assaig clínic" @default.
- Q63403278 description "clinical trial" @default.
- Q63403278 description "clinical trial" @default.
- Q63403278 description "clinical trial" @default.
- Q63403278 description "clinical trial" @default.
- Q63403278 description "ensaio clínico" @default.
- Q63403278 description "ensayo clínico" @default.
- Q63403278 description "ensayu clínicu" @default.
- Q63403278 description "essai clinique" @default.
- Q63403278 description "klinisch onderzoek" @default.
- Q63403278 description "клінічне випробування" @default.
- Q63403278 name "Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency" @default.
- Q63403278 type Item @default.
- Q63403278 label "Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency" @default.
- Q63403278 prefLabel "Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency" @default.
- Q63403278 P1050 Q63403278-014B15AC-4DF2-44DE-BE58-F9DB4D6797E4 @default.
- Q63403278 P1050 Q63403278-D64BDD4B-5B69-4905-81D4-FD0635B4B064 @default.
- Q63403278 P1132 Q63403278-82871D3A-23BC-42C2-809C-30B70D0E9999 @default.
- Q63403278 P1476 Q63403278-22FA0FBE-5324-4236-A43D-CBEC9AB3C68C @default.
- Q63403278 P17 Q63403278-EE0F6400-D244-4EA5-A866-360E2D7047B6 @default.
- Q63403278 P2899 Q63403278-C18F50B4-EA83-4C09-AA13-3051BBA91418 @default.
- Q63403278 P3098 Q63403278-6E6F27C8-E0C6-4876-861B-E134DF24E3D9 @default.
- Q63403278 P31 Q63403278-6379F405-6D38-4745-9B6A-3D93D23BD4DE @default.
- Q63403278 P4844 Q63403278-245FE05B-0EBE-4082-802A-A083CB578D85 @default.
- Q63403278 P4844 Q63403278-3C2E1371-096D-4AB9-BE6C-CDAF6BB97B70 @default.
- Q63403278 P4844 Q63403278-E18B0E7E-8E67-4D65-A6B5-35372F2BAFDC @default.
- Q63403278 P580 Q63403278-E9080B2B-EE25-44B6-8916-C5AEB5A1E263 @default.
- Q63403278 P582 Q63403278-F4FBF24F-E11D-4B6D-AF6A-66E2E4134C62 @default.
- Q63403278 P6099 Q63403278-174AF813-4C44-4096-AB4A-C54EB60BFD0C @default.
- Q63403278 P6153 Q63403278-35F12477-4FCD-4C00-87E0-01AA475340D0 @default.
- Q63403278 P8363 Q63403278-FA633DC8-7C23-4116-B92A-4ABF10DEEDEA @default.
- Q63403278 P859 Q63403278-9B1DC97D-B91E-4838-962A-54E9556E3B01 @default.
- Q63403278 P1050 Q33525 @default.
- Q63403278 P1050 Q356033 @default.
- Q63403278 P1132 "+20" @default.
- Q63403278 P1476 "PLATI-PARP: A Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in Treatment of Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency" @default.
- Q63403278 P17 Q30 @default.
- Q63403278 P2899 "+18" @default.
- Q63403278 P3098 "NCT03442556" @default.
- Q63403278 P31 Q30612 @default.
- Q63403278 P4844 Q415588 @default.
- Q63403278 P4844 Q420436 @default.
- Q63403278 P4844 Q7376558 @default.
- Q63403278 P580 "2018-08-24T00:00:00Z" @default.
- Q63403278 P582 "2024-05-15T00:00:00Z" @default.
- Q63403278 P6099 Q42824440 @default.
- Q63403278 P6153 Q219563 @default.
- Q63403278 P8363 Q78089383 @default.
- Q63403278 P859 Q219563 @default.